U.S. FDA advisers vote in favor of Pfizer/BioNTech COVID-19 vaccine in young kids

/
1 min read
FILE PHOTO: Picture illustration of a vial labelled with the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine

– A panel of outside advisers to the U.S. Food and Drug Administration on Tuesday voted to recommend the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages five to 11 years.

(Reporting by Manas Mishra in Bengaluru; Editing by Bill Berkrot)

tagreuters.com2021binary_LYNXMPEH9P1AC-BASEIMAGE

tagreuters.com2021binary_LYNXMPEH9P1AB-BASEIMAGE


Breaking News
Ukraine will get worse for isolated Russia, analyst says on state TV